Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment

Pharmacogenet Genomics. 2011 Sep;21(9):587-9. doi: 10.1097/FPC.0b013e32834910d1.

Abstract

We have demonstrated that 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT), reduces intraocular pressure (IOP) in rabbits. In addition, we have reported a link between hypotensive effect of 5-MCA-NAT and sympathetic nervous system. Moreover, it is known that aqueous humour production is controlled by the activation of adrenoceptors (ADRs) present in the ocular ciliary epithelium. Thus, the aim of this study is to investigate if the hypotensive effect of 5-MCA-NAT is due to a regulation of ciliary ADR genes expression. To confirm this we followed the effect of 5-MCA-NAT on rabbit IOP for 144 consecutive hours. A sustained IOP reduction for up to 72 h (P<0.01) was seen. In addition, changes in ADRB2 and ADRA2A mRNA were measured in cultured rabbit nonpigmented ciliary epithelial cells. After 5-MCA-NAT treatment, a significant downregulation of ADRB2 and upregulation of ADRA2A was observed. These results provide the regulation of ADRs mRNA by 5-MCA-NAT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ciliary Body / metabolism
  • Gene Expression Regulation / drug effects*
  • Glaucoma / drug therapy
  • Intraocular Pressure / genetics
  • Pigment Epithelium of Eye / metabolism
  • Rabbits
  • Receptors, Adrenergic / genetics*
  • Sympathetic Nervous System / drug effects
  • Tryptamines / pharmacology*

Substances

  • 5-methoxycarbonylamino-N-acetyltryptamine
  • Receptors, Adrenergic
  • Tryptamines